"Receptors, CCR6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CCR receptors with specificity for CHEMOKINE CCL20. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; and DENDRITIC CELLS.
| Descriptor ID |
D054399
|
| MeSH Number(s) |
D12.776.543.750.695.160.150.600 D12.776.543.750.705.852.125.150.600
|
| Concept/Terms |
Receptors, CCR6- Receptors, CCR6
- CCR6 Receptors
- Antigens, CD196
- CC Chemokine Receptor 6
- CC Chemokine Receptors 6
- CD196 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Receptors, CCR6".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CCR [D12.776.543.750.695.160.150]
- Receptors, CCR6 [D12.776.543.750.695.160.150.600]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CCR [D12.776.543.750.705.852.125.150]
- Receptors, CCR6 [D12.776.543.750.705.852.125.150.600]
Below are MeSH descriptors whose meaning is more specific than "Receptors, CCR6".
This graph shows the total number of publications written about "Receptors, CCR6" by people in this website by year, and whether "Receptors, CCR6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, CCR6" by people in Profiles.
-
Kapur N, Mir H, Clark Iii CE, Krishnamurti U, Beech DJ, Lillard JW, Singh S. CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition. Br J Cancer. 2016 06 14; 114(12):1343-51.